Quarterly report pursuant to Section 13 or 15(d)

Financing (Details)

v3.20.2
Financing (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Jun. 09, 2020
Oct. 21, 2019
Sep. 18, 2018
Jul. 31, 2020
Oct. 31, 2019
Sep. 23, 2020
Sep. 30, 2020
Jun. 30, 2020
Sep. 30, 2020
Sep. 30, 2019
Nov. 30, 2019
Debt Instrument [Line Items]                      
Repayments of related party debt                 $ 350 $ 0  
Fair value of common stock exchanged to settle Note Payable             $ 1,047 $ 531      
Redemption, upon three business days' notice                      
Debt Instrument [Line Items]                      
Debt instrument term         6 months            
Common Stock                      
Debt Instrument [Line Items]                      
Share issued upon conversion             246 153      
NDX | Credit Agreement                      
Debt Instrument [Line Items]                      
Payments on Advance from NovellusDx, Ltd.     $ 1,500                
Repayments of related party debt   $ 100   $ 50 $ 1,000            
Long-term line of credit         $ 450            
Due to affiliate                     $ 50
Conversion price (in usd per share)         $ 4.50            
Stated interest rate         0.00%            
Atlas Sciences                      
Debt Instrument [Line Items]                      
Stated interest rate         10.00%            
Debt instrument term         12 months            
Term note, principal balance         $ 1,300            
Gross consideration         1,300            
Debt issuance discount         88            
Interest and debt expense         10            
Maximum monthly redemption         $ 300            
Annual interest rate         22.00%            
Repayments of principal amount $ 500                    
Atlas Sciences | Common Stock                      
Debt Instrument [Line Items]                      
Share issued upon conversion 153         246          
Fair value of common stock exchanged to settle Note Payable $ 531         $ 1,050